Looking over the deleted posts, all were done by flafly. 

New Post Public Reply Private Reply Replies (0) Message Board
thehawk72

Looking over the deleted posts, all were done by flafly.  To delete SGR's post regarding "only" testing of produce speaks volumes.  Testing food is what MMTC is all about.  Trying to keep this one down at all costs.

Don't know who or why we currently have sellers, but we can all reach our own opinions.  Picked up 2mil on Monday.  Maybe I should have waited, but as quick as this could go down, it can go up just as fast.  I've been betting on MMTC for over 18 months, and although I watch it like a hawk, I only step back occasionally to re-evaluate my position.  Each time I come away from that evaluation and see the incredible upside potential here.

MMTC is far from a bed of roses, and that is why we are at the pps level we are today.

BTW, my evaluation concludes that MMTC is not even close to a scam.  Doesn't mean they will make it, but I've yet to find another stock where I'm willing to put my investment in.

Nunez will make this run.  I'm looking for the run to follow news that will sustain the run and allow consolidation to happen at a much higher level.  If that happens, and not just a self induced run, holding patiently during the consolidation will be easy to do.

GLTA...see you all on IH, ihub is the new yahoo

Micro Imaging Technology Inc. (MMTC) Stock Research Links

MMTC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Coca-Cola's Recent Unusual Options Trends

Updated Category News Views 259

Analyzing Coca-Cola's Recent Options Activity Investors are showing a bearish trend toward Coca-Cola (KO), which is an important indicator for retail traders monitoring investment trends. The recent unusual options activity suggests that these investors may possess insights not yet shared with the public. Thus, individual traders should be particularly attentive to these...

Continue Reading
Sustainable Palm Oil Market Growth Driven by AI Insights

Updated Category News Views 136

Exploring the Growth of the Sustainable Palm Oil Market The sustainable palm oil market is currently on the rise, fueled by a growing demand for trans-fat-free products and innovations in eco-friendly farming practices. This growth is expected to hit around USD 2.75 billion by 2028, reflecting a solid compound annual growth rate (CAGR) of about 5.24% in the coming years....

Continue Reading
Grilling Safety Tips from Ferrellgas This Labor Day

Updated Category News Views 82

Grilling Safety Tips from Ferrellgas This Labor Day As we gear up for one of the biggest grilling holidays of the year, it's essential to keep safety in mind while savoring delicious meals with family and friends. Ferrellgas Partners, L.P. is taking this opportunity to remind customers about the significance of safe grilling practices this Labor Day. This holiday not only...

Continue Reading
Solstice Gold Secures Funding Through Successful Placement Deal

Updated Category News Views 127

Solstice Gold Completes Successful Private Placement Financing Solstice Gold Corp. (“Solstice”, “we”, “our”, or the “Company”) is thrilled to announce the successful closing of its private placement financing. This significant financial milestone comes with gross proceeds of approximately $150,000 from the issuance of 6,600,000 shares. This private...

Continue Reading
Avanos Medical Introduces Innovative CORGRIP SR System

Updated Category News Views 32

Avanos Medical Launches New CORGRIP SR Advancement to reduce dislodgement in feeding tube retention systems Avanos Medical, Inc. (NYSE: AVNS) recently announced an exciting development in its Enteral Feeding portfolio with the launch of the CORGRIP SR Nasogastric/Nasointestinal Tube Retention System. This innovative design aims to provide enhanced support and security for...

Continue Reading